Health
Study finds Neuroprotectant delivered to the brain in nanoparticles may improve stroke treatment – NeuroNews International
Preliminary research to be presented at the International Stroke Conference (ISC) 2021 meeting (17–19 March, virtual) has found that when NA1, a neuroprotectant,…
Jiangbing Zhou
Preliminary research to be presented at the International Stroke Conference (ISC) 2021 meeting (1719 March, virtual) has found that when NA1, a neuroprotectant, was delivered to the brain in nanoparticles, it reduced stroke severity and improved survival in a mouse model of stroke.
In an earlier human trial (the ESCAPE-NA1 trial), NA1, a small peptide designed to save brain cells from death after stroke, showed mixed results when NA1 was administered to patients undergoing clot removal…
-
Business15 hours agoBattle of the ASX ETFs: Why has VGS outperformed VTS this year?
-
General24 hours agoLiberals dump NSW candidate who said women should not serve in ADF combat
-
Business11 hours ago1 ASX dividend stock down 43% I’d buy right now
-
General21 hours agoCoalition abandons ‘end’ to work from home, walks back 41,000 job cuts